Related content

Targeting the dopamine D₁ receptor in schizophrenia: insights for cognitive dysfunction

By Goldman-Rakic Patricia   Castner Stacy   Svensson Torgny   Siever Larry   Williams Graham  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 3-16

Springer Publishing Company

Access to resources Recommend Favorite

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms

By Güzey Cüneyt   Scordo Maria   Spina Edoardo   Landsem Veslemøy   Spigset Olav  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 233-241

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine D 2 and D 4 receptor ligands: relation to antipsychotic action

By Wilson J.M.   Sanyal S.   Van Tol H.H.M.  

European Journal of Pharmacology, Vol. 351, Iss. 3, 1998-06 ,pp. : 273-286

Elsevier

Access to resources Recommend Favorite

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

By Keck Jr Paul E   McElroy Susan L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 655-662

Informa Healthcare

Access to resources Recommend Favorite

Sexual Dysfunction in Male Patients with Hypertension: Influence of Antihypertensive Drugs

By Düsing Rainer  

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 773-786

Adis International

Access to resources Recommend Favorite